查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1983872

神经系统医疗设备市场：依产品、应用、最终用户和通路划分－2026-2032年全球市场预测

Neurology Devices Market by Product, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，神经医疗设备市场价值将达到 139.6 亿美元，到 2026 年将成长至 153.3 亿美元，到 2032 年将达到 282.1 亿美元，复合年增长率为 10.57%。

主要市场统计数据
基准年 2025 139.6亿美元
预计年份：2026年 153.3亿美元
预测年份 2032 282.1亿美元
复合年增长率 (%) 10.57%

在技​​术快速发展和监管变革的时代，本文探讨了塑造先进神经医疗设备。

神经医疗设备领域正处于一个关键的转折点，技术的飞跃和临床实践的变革正在迅速改变患者照护通讯协定。随着精准医疗的兴起，器材研发人员正在整合先进的感测器、人工智慧和尖端材料，以提供根据每位患者独特的神经生理特征量身定制的个人化治疗方案。这种向个人化治疗的转变源于不断累积的临床证据，这些证据表明个人化治疗能够改善治疗效果并减少不利事件。

新兴技术、临床范式转变和跨学科整合如何重新定义神经医疗设备的发展和患者照护路径。

在跨学科整合和以病人为中心的设计理念的驱动下，一场变革浪潮正在重塑神经医疗设备领域。神经影像学和术中导航技术的快速发展，使得微创手术成为新的治疗标准，显着缩短了手术时间，并加快了患者康復。同时，植入式神经调控系统的普及，正透过封闭回路型回馈机制，显着提高疗效和安全性，从而重新定义从慢性疼痛到神经退化性疾病等多种疾病的治疗模式。

评估 2025 年美国关税对神经医疗设备。

美国在2025年实施的关税政策为神经医疗设备生态系统带来了巨大挑战，影响价值链的每一个环节。面对进口零件关税的上涨，製造商被迫重新思考筹资策略，一些公司将部分生产转移到更靠近终端市场的地方，以降低成本。虽然这种近岸生产模式在一定程度上缓解了供应链的脆弱性，但也需要对国内基础设施进行大量资本投资。

阐明神经医疗设备领域中，产品、应用、最终用户和通路的关键细分模式，进而推动策略决策。

关键细分市场分析揭示了影响技术采纳和投资的微妙因素，突显了临床和商业性优先事项的交会点。产品趋势评估表明，从脑脊髓液（CSF）管理装置（如脑外引流和脑分流器）到介入性神经病学工具（如动脉瘤栓塞术、球囊血管成形术和支架、神经血栓切除术以及神经血管导管），每项技术都有其独特的创新需求。在动脉瘤栓塞术领域，栓塞线圈、血流导引装置和液体栓塞剂因其在降低復发率方面的作用而备受关注；而脑球囊血管成形术和支架策略则着重于优化球囊闭塞、颈动脉支架和滤器装置的器械特性。同样，神经血栓切除术的进展凸显了血栓移除装置、勒除器器和抽吸系统的发展；而不断扩展的神经刺激疗法领域则包括深部脑部刺激、胃电刺激、荐椎神经刺激、脊髓刺激和迷走神经刺激。最后，动脉瘤夹、神经科学用内视镜、立体定位手术系统和超音波吸引器等神经外科器械的进步，也反映了人们对精准性和微创性的持续追求。

分析美洲、欧洲、中东和非洲以及亚太地区神经医疗设备普及路径所面临的区域机会和挑战。

区域趋势在塑造神经医疗设备市场的发展轨迹中发挥着至关重要的作用，因为不同的医疗基础设施、报销系统和患者群体都会影响产品的普及率。在美洲，成熟的大学医院网路和有利于数位疗法的法规环境正在推动先进监测和神经调控系统的快速普及。然而，控制医疗成本的压力以及向价值医疗模式的转变，使得人们更加关注产品的长期临床效益。

透过对主要企业和创新者的分析，突显神经医疗设备。

主要企业和新兴创新者正透过策略联盟、定向研发投资和开发整合式医疗模式，树立新的产业标竿。成熟企业正深化与学术机构的伙伴关係，共同开发融合先进感测技术与自适应演算法的下一代神经刺激平台。同时，创业投资支持的Start-Ups在生物电子和软体机器人领域开拓创新，成功展示了概念验证（PoC）项目，并吸引了许多授权和收购者的注意。

为产业领导者提供策略蓝图，帮助他们应对监管的复杂性，利用技术进步，并巩固其在神经医疗设备领域的地位。

产业领导者必须采取前瞻性策略，使研发重点与不断发展的临床和监管范式保持一致。企业应优先开发能够支援多种适应症的平台技术，从而最大限度地提高投资回报率并促进跨职能协同效应。投资强大的数据分析和远端监测能力将有助于产生真实世界数据 (RWE)，而真实世界数据对于获得有利的报销条款和支付方协议正变得越来越重要。

采用综合研究途径，结合一手访谈、二手资料分析和统计检验，以确保对神经医疗设备有可靠的了解。

本研究采用多阶段方法，确保研究结果的可靠性和有效性。主要资料收集包括对关键意见领袖（KOL）进行结构化访谈，访谈对象包括神经科、介入放射科医生和医疗设备工程师，旨在获取他们对未满足需求和创新瓶颈的第一手观点。次要研究资料来源包括监管资料库、临床试验註册资讯和同行评审文献，以提供有关产品平臺和核准趋势的背景资讯。

本报告整合了关键发现和策略挑战，揭示了神经医疗设备市场的未来发展方向和投资机会。

神经系统医疗器材领域的特点是技术快速发展、医保报销模式不断演变、监管环境日益复杂。分析表明，整合数位智慧、深化策略伙伴关係并保持敏捷生产体系的企业更有可能取得成功。透过封闭回路型调控和微创手术实现的个人化治疗将推动下一波临床突破。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：神经医疗设备市场：依产品划分

  • 脑脊髓液管理装置
    • 神经系统外引流
    • 脑分流
  • 介入性神经病学
    • 动脉瘤弹簧圈栓塞术及栓塞术
      • 栓塞线圈
      • 血液旁路装置
      • 液态栓塞剂
    • 脑血管球囊成形术及支架植入术
      • 球囊阻塞装置
      • 颈动脉支架
      • 过滤装置
    • 神经血栓切除术
      • 血栓清除器
      • 勒除器装置
      • 吸力装置
    • 神经血管导管
  • 神经刺激
    • 深部脑部刺激
    • 胃电刺激
    • 荐椎神经刺激
    • 脊髓刺激疗法
    • 迷走神经刺激
  • 神经外科器械
    • 动脉瘤夹
    • 神经科学用内视镜
    • 定位系统
    • 超音波吸引器

第九章：神经医疗设备市场：依应用领域划分

  • 慢性疼痛
  • 癫痫和癫痫发作
    • 癫痫的诊断和监测
    • 癫痫控制装置
  • 精神疾病
    • 焦虑
    • 忧郁症
    • 思觉失调症
  • 多发性硬化症（MS）
  • 神经退化性疾病
    • 阿兹海默症
    • 肌萎缩侧索硬化症（ALS）
    • 亨丁顿舞蹈症
    • 帕金森氏症
  • 神经血管疾病
  • 脊髓损伤
  • 中风
    • 用于治疗出血性中风的医疗设备
    • 用于治疗缺血性中风的医疗设备
    • 中风復健设备
  • 创伤性脑损伤（TBI）

第十章：神经医疗设备市场：依最终用户划分

  • 学术和研究机构
  • 诊断中心
  • 居家照护
  • 医院
  • 神经科诊所
  • 復健中心

第十一章：神经医疗设备市场：依分销管道划分

  • 离线
  • 在线的

第十二章 神经系统医疗设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：神经医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 神经医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国神经医疗设备市场

第十六章：中国神经医疗设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Acandis GmbH
  • B. Braun SE
  • Boston Scientific Corporation
  • Esaote SpA
  • GE HealthCare Technologies, Inc.
  • Integra LifeSciences Holdings
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Penumbra Inc.
  • Rapid Medical Ltd.
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-F6513A06BEEC

The Neurology Devices Market was valued at USD 13.96 billion in 2025 and is projected to grow to USD 15.33 billion in 2026, with a CAGR of 10.57%, reaching USD 28.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.96 billion
Estimated Year [2026] USD 15.33 billion
Forecast Year [2032] USD 28.21 billion
CAGR (%) 10.57%

Discover the Unfolding Innovations and Challenges Shaping Advanced Neurology Devices in an Era of Rapid Technological Evolution and Regulatory Shifts

The field of neurology devices stands at a pivotal juncture, where breakthroughs in technology and shifts in clinical practice are rapidly altering patient care protocols. As precision medicine gains momentum, device developers are integrating sophisticated sensors, artificial intelligence, and advanced materials to deliver tailored therapies that align with the unique neurophysiological profiles of patients. This drive toward personalization is fueled by a growing body of clinical evidence demonstrating improved outcomes and reduced adverse events.

Regulatory landscapes are also evolving, with agencies worldwide emphasizing post-market surveillance, cybersecurity standards, and streamlined pathways for digital therapeutics. At the same time, healthcare providers are under mounting pressure to demonstrate value, leading to increased collaboration between device manufacturers, payers, and clinical networks. Against this backdrop, a clear understanding of the interplay between innovation, regulation, and market access has never been more critical for stakeholders seeking to navigate complexity and capitalize on emerging opportunities.

How Emerging Technologies, Clinical Paradigm Shifts, and Cross-Disciplinary Integration Are Redefining Neurology Device Development and Patient Care Pathways

A wave of transformative shifts is reshaping the neurology devices landscape, driven by cross-disciplinary convergence and patient-centric design philosophies. Rapid advances in neuroimaging and intraoperative navigation have enabled minimally invasive interventions to become the new standard of care, reducing procedure times and accelerating recovery. In parallel, the proliferation of implantable neuromodulation systems is redefining therapeutic paradigms for conditions ranging from chronic pain to neurodegenerative disorders, with closed-loop feedback mechanisms enhancing efficacy and safety.

Meanwhile, the integration of machine learning algorithms into diagnostic platforms is unlocking predictive capabilities that were previously unattainable. This is complemented by the emergence of digital biomarkers, which harness wearable sensors and remote monitoring to capture rich datasets in real time. As industry players forge partnerships with technology innovators and academic centers, new business models are taking shape that prioritize outcome-based agreements and digital services alongside traditional capital equipment. Consequently, stakeholders must remain agile, anticipating how these converging trends will dictate the next frontier of clinical performance and commercial success.

Assessing the Aggregate Consequences of 2025 United States Tariffs on Neurology Device Supply Chains, Cost Structures, and Competitive Dynamics

The implementation of United States tariffs in 2025 has introduced significant headwinds for the neurology devices ecosystem, affecting every stage of the value chain. Manufacturers facing elevated duties on imported components have had to reassess sourcing strategies, with some relocating portions of production closer to end markets to mitigate cost impacts. This shift toward nearshoring has alleviated certain supply chain vulnerabilities, yet it has also necessitated substantial capital investment in domestic infrastructure.

On the demand side, hospitals and clinics are increasingly scrutinizing total cost of ownership, compelling device suppliers to justify price adjustments with demonstrable clinical and operational benefits. In response, vendors are accelerating innovation cycles, embedding connectivity features that support remote diagnostics and predictive maintenance to counterbalance tariff-induced price pressures. At the same time, collaborative consortia are emerging to share best practices in procurement and logistics, reinforcing resilience against future trade policy fluctuations. As a result, companies that proactively adapt their manufacturing footprint and value propositions are better positioned to sustain growth in this new trade environment.

Unveiling Key Segmentation Patterns Across Products, Applications, End Users, and Distribution Channels That Drive Strategic Decision Making in Neurology Devices

Critical segmentation analysis reveals nuanced drivers of adoption and investment, highlighting where clinical and commercial priorities intersect. When evaluating the product landscape, it becomes evident that technologies spanning CSF Management Devices-such as cerebral external drainage and cerebral shunts-and Interventional Neurology tools for aneurysm coiling and embolization, balloon angioplasty & stents, neurothromboectomy, and neurovascular catheters each present distinct innovation imperatives. Within aneurysm coiling and embolization, embolic coils, flow diversion devices, and liquid embolic reagents command attention for their role in reducing recurrence rates, while cerebral balloon angioplasty & stents strategies focus on optimizing device profiles for balloon occlusion, carotid artery stents, and filter devices. Equally, the evolution of neurothromboectomy highlights clot retrievers, snare devices, and suction aspiration systems, and the expanding realm of neurostimulation encompasses deep brain stimulation, gastric electric stimulation, sacral nerve stimulation, spinal cord stimulation, and vagus nerve stimulation. Finally, advances in neurosurgery devices like aneurysm clips, neuroendoscopes, stereotactic systems, and ultrasonic aspirators underscore the ongoing push toward precision and minimal invasiveness.

Similarly, application-based segmentation underscores the varying unmet needs across therapeutic areas. In chronic pain management, the emphasis is on long-term safety and patient comfort, whereas epilepsy & seizure disorders demand robust solutions for diagnosis & monitoring of epilepsy and seizure control devices. Treatment pathways for mental health disorders-including anxiety, depression, and schizophrenia-are evolving with neurostimulation and closed-loop monitoring, and multiple sclerosis strategies must accommodate both relapsing and progressive forms. Neurodegenerative disorder profiles span Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Parkinson's disease, each requiring distinct device capabilities. Neurovascular disorders present acute intervention challenges, spinal cord injuries call for regenerative and assistive technologies, and stroke care differentiates between hemorrhagic stroke devices, ischemic stroke devices, and stroke rehabilitation devices. Traumatic brain injury remains a high-priority area for intracranial pressure management and neurorehabilitation.

On the end-user front, the ecosystem stretches from academic & research institutes and diagnostic centers to home care, hospitals, neurology clinics, and rehabilitation centers, each setting imposing unique training, reimbursement, and integration requirements. Distribution channels, whether offline or online, further shape go-to-market strategies, impacting everything from product demonstrations to post-sales support.

Analyzing Regional Opportunities and Challenges in the Americas, Europe Middle East Africa, and Asia Pacific That Shape Neurology Device Adoption Pathways

Regional dynamics play an outsized role in shaping the trajectory of neurology device markets, as diverse healthcare infrastructures, reimbursement frameworks, and patient demographics influence adoption rates. In the Americas, a well-established network of academic medical centers and a favorable regulatory climate for digital therapeutics support rapid uptake of advanced monitoring and neuromodulation systems. Yet cost containment pressures and shifts toward value-based care models are driving heightened scrutiny of long-term clinical benefits.

Europe Middle East Africa embodies a mosaic of markets where regulatory harmonization under evolving directives intersects with national payer negotiations. This environment creates both barriers and opportunities for device innovators, particularly those leveraging real-world evidence to substantiate outcomes. Growing investments in neurovascular centers of excellence are enhancing the profile of interventional neurology and stroke rehabilitation technologies.

In Asia Pacific, dynamic growth is underpinned by expanding healthcare budgets, rising incidence of neurological disorders, and government initiatives to bolster domestic manufacturing capabilities. Local partnerships and licensing agreements have become essential pathways for global manufacturers seeking to navigate diverse regulatory landscapes and accelerate market entry. Consequently, stakeholders must adopt differentiated regional strategies that account for local standards, reimbursement pathways, and clinician training requirements.

Profiling Leading Players and Innovators to Highlight Strategic Collaborations, Innovation Pathways, and Competitive Differentiators in Neurology Devices

Leading players and rising innovators are establishing new benchmarks through strategic collaborations, targeted research and development investments, and the creation of integrated care models. Established firms are deepening partnerships with academic centers to co-develop next-generation neurostimulation platforms that incorporate advanced sensing and adaptive algorithms. Concurrently, venture-backed startups are pioneering bioelectronics and soft robotics, demonstrating proof-of-concept successes that are attracting licensing and acquisition interest.

Partnerships between device manufacturers and digital health providers are expanding the scope of remote patient management, with cross-industry alliances enabling the incorporation of cloud-based analytics and telemedicine workflows. Patent portfolios and regulatory approvals serve as key differentiators, and companies that maintain a balanced mix of incremental enhancements and disruptive breakthroughs are consistently outperforming peers in clinical acceptance. As M&A activity accelerates in areas such as minimally invasive interventional neurology and closed-loop neuromodulation, market leadership hinges on the ability to integrate complementary assets and scale solutions across global markets.

Strategic Roadmap for Industry Leaders to Navigate Regulatory Complexities, Capitalize on Technological Advances, and Strengthen Position in Neurology Devices

Industry leaders must adopt a forward-looking strategy that aligns R&D priorities with evolving clinical and regulatory paradigms. Companies should prioritize the development of platform technologies capable of supporting multiple indications, thereby maximizing return on investment and facilitating cross-functional synergies. Investing in robust data analytics and remote monitoring capabilities will enhance real-world evidence generation, which is increasingly vital for securing favorable reimbursement and payer contracts.

At the same time, regional supply chain diversification and nearshoring initiatives should be advanced to buffer against future trade policy disruptions. Engaging early with regulatory agencies on digital health guidelines and post-market surveillance expectations can streamline approval pathways and minimize time to market. Finally, forging collaborative ecosystems with healthcare providers, technology firms, and patient advocacy groups will accelerate adoption and ensure that product roadmaps remain closely aligned with unmet clinical needs.

Comprehensive Research Approach Combining Primary Interviews, Secondary Data Analysis, and Statistical Validation to Ensure Robust Insights in Neurology Devices

This research employs a multi-phased approach to ensure the integrity and relevance of insights. Primary data collection involved structured interviews with key opinion leaders, including neurologists, interventional radiologists, and device engineers, to capture firsthand perspectives on unmet needs and innovation bottlenecks. Secondary research sources encompassed regulatory databases, clinical trial registries, and peer-reviewed literature to contextualize product pipelines and approval trends.

Quantitative analysis was conducted using a rigorous data triangulation framework that reconciled manufacturer disclosures, hospital procurement records, and publicly available financial reports. Statistical validation techniques were applied to identify significant trends and correlations. An expert advisory board reviewed intermediate findings to refine assumptions and interpret emerging themes, thereby ensuring that the final deliverables reflect both empirical evidence and real-world clinical practice.

Synthesizing Key Findings and Strategic Imperatives to Illuminate Future Directions and Investment Opportunities in the Neurology Devices Landscape

The neurology devices landscape is defined by rapid technological advancement, shifting reimbursement models, and increasingly complex regulatory frameworks. Through this analysis, it is clear that success will favor organizations that integrate digital intelligence, deepen strategic partnerships, and maintain agile manufacturing footprints. Personalization of therapies through closed-loop neuromodulation and minimally invasive interventions is set to drive the next wave of clinical breakthroughs.

Looking forward, industry players that invest in scalable platform technologies and robust evidence generation will be best positioned to capture new opportunities. Cross-border collaboration and adaptive regulatory engagement will accelerate commercialization, ultimately improving patient outcomes and unlocking sustainable growth. The insights presented here form a blueprint for navigating uncertainty and charting a course toward continued innovation in neurology care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurology Devices Market, by Product

  • 8.1. CSF Management Devices
    • 8.1.1. Cerebral External Drainage
    • 8.1.2. Cerebral Shunts
  • 8.2. Interventional Neurology
    • 8.2.1. Aneurysm Coiling and Embolization
      • 8.2.1.1. Embolic Coils
      • 8.2.1.2. Flow Diversion Devices
      • 8.2.1.3. Liquid Embolic Reagents
    • 8.2.2. Cerebral Balloon Angioplasty & Stents
      • 8.2.2.1. Balloon Occlusion Devices
      • 8.2.2.2. Carotid Artery Stents
      • 8.2.2.3. Filter Devices
    • 8.2.3. Neurothromobectomy
      • 8.2.3.1. Clot Retrievers
      • 8.2.3.2. Snare Devices
      • 8.2.3.3. Suction Aspiration Devices
    • 8.2.4. Neurovascular Catheters
  • 8.3. Neurostimulation
    • 8.3.1. Deep Brain Stimulation
    • 8.3.2. Gastric Electric Stimulation
    • 8.3.3. Sacral Nerve Stimulation
    • 8.3.4. Spinal Cord Stimulation
    • 8.3.5. Vagus Nerve Stimulation
  • 8.4. Neurosurgery Devices
    • 8.4.1. Aneurysm Clips
    • 8.4.2. Neuroendoscopes
    • 8.4.3. Stereotactic Systems
    • 8.4.4. Ultrasonic Aspirators

9. Neurology Devices Market, by Application

  • 9.1. Chronic Pain
  • 9.2. Epilepsy & Seizure Disorders
    • 9.2.1. Diagnosis & Monitoring of Epilepsy
    • 9.2.2. Seizure Control Devices
  • 9.3. Mental Health Disorders
    • 9.3.1. Anxiety
    • 9.3.2. Depression
    • 9.3.3. Schizophrenia
  • 9.4. Multiple Sclerosis (MS)
  • 9.5. Neurodegenerative Disorders
    • 9.5.1. Alzheimer's Disease
    • 9.5.2. Amyotrophic Lateral Sclerosis (ALS)
    • 9.5.3. Huntington's Disease
    • 9.5.4. Parkinson's Disease
  • 9.6. Neurovascular Disorders
  • 9.7. Spinal Cord Injuries
  • 9.8. Stroke
    • 9.8.1. Hemorrhagic Stroke Devices
    • 9.8.2. Ischemic Stroke Devices
    • 9.8.3. Stroke Rehabilitation Devices
  • 9.9. Traumatic Brain Injury (TBI)

10. Neurology Devices Market, by End User

  • 10.1. Academic & Research Institutes
  • 10.2. Diagnostic Centers
  • 10.3. Home Care
  • 10.4. Hospitals
  • 10.5. Neurology Clinics
  • 10.6. Rehabilitation Centers

11. Neurology Devices Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Neurology Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurology Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurology Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Neurology Devices Market

16. China Neurology Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Acandis GmbH
  • 17.7. B. Braun SE
  • 17.8. Boston Scientific Corporation
  • 17.9. Esaote SpA
  • 17.10. GE HealthCare Technologies, Inc.
  • 17.11. Integra LifeSciences Holdings
  • 17.12. Koninklijke Philips N.V.
  • 17.13. Masimo Corporation
  • 17.14. Medtronic PLC
  • 17.15. MicroPort Scientific Corporation
  • 17.16. Natus Medical Inc.
  • 17.17. Nihon Kohden Corporation
  • 17.18. Penumbra Inc.
  • 17.19. Rapid Medical Ltd.
  • 17.20. Siemens Healthcare GmbH
  • 17.21. Stryker Corporation
  • 17.22. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 287. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2032 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2032 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC